Preoperative Left Ventricular Thrombus and Midterm Outcomes Following Left Ventricular Assist Device Support

Background: Preoperative left ventricular thrombus (LVT) may complicate left ventricular assist device (LVAD) implantation by increasing surgical complexity and potentially predisposing patients to thromboembolic events. However, the clinical significance of LVT in the era of LVAD support remains unclear. This study aimed to evaluate whether preoperative LVT influences early and mid-term outcomes after durable LVAD implantation. Methods: This retrospective, single-center cohort study included 81 adult patients who underwent LVAD implantation between January 2012 and December 2024. Twenty-one patients had documented preoperative LVT. Propensity score matching (1:1) was performed, resulting in 21 matched pairs. All patients with LVT underwent intraoperative thrombectomy. Postoperative outcomes included ischemic and hemorrhagic stroke, pump thrombosis, infectious complications, ventricular arrhythmias, duration of device support, and postoperative echocardiographic parameters. Results: After matching, baseline characteristics were generally comparable. Ischemic stroke incidence was identical (4.8% vs. 4.8%). Hemorrhagic stroke occurred in one LVT patient (4.8%) and in none of the controls. Pump thrombosis was numerically higher in LVT patients (9.5% vs. 4.8%) but not statistically significant. Rates of driveline infection (33.3% vs. 57.1%), bloodstream infection (19.0% vs. 28.6%), and ventricular arrhythmias (19.0% vs. 23.8%) were similar. Postoperative echocardiographic parameters and aortic valve opening patterns were comparable. The median LVAD support duration did not differ significantly (1003 vs. 821 days). Conclusions: Preoperative LVT was not associated with statistically significant differences in adverse outcomes following LVAD implantation when managed with surgical thrombectomy and standardized anticoagulation. However, given the small matched cohort and wide confidence intervals, clinically meaningful differences cannot be excluded. These findings require confirmation in larger prospective studies.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-04-27
DOI
https://doi.org/10.3390/jcm15093322
Primary Topic
Mechanical Circulatory Support Devices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Preoperative Left Ventricular Thrombus and Midterm Outcomes Following Left Ventricular Assist Device Support

Sanem Nalbantgil, Ahmet Daylan, Sedat Karaca, Çağatay Engin et al.
Journal of Clinical Medicine
Mechanical Circulatory Support Devices
article

Preoperative Left Ventricular Thrombus and Midterm Outcomes Following Left Ventricular Assist Device Support

Sanem Nalbantgil, Ahmet Daylan, Sedat Karaca, Çağatay Engin, Ümit Kahraman, Mustafa Özbaran, Serkan Ertugay, Emrah Oğuz, Tahir Yağdı, Berk Dacik
article en

Abstract

Background: Preoperative left ventricular thrombus (LVT) may complicate left ventricular assist device (LVAD) implantation by increasing surgical complexity and potentially predisposing patients to thromboembolic events. However, the clinical significance of LVT in the era of LVAD support remains unclear. This study aimed to evaluate whether preoperative LVT influences early and mid-term outcomes after durable LVAD implantation. Methods: This retrospective, single-center cohort study included 81 adult patients who underwent LVAD implantation between January 2012 and December 2024. Twenty-one patients had documented preoperative LVT. Propensity score matching (1:1) was performed, resulting in 21 matched pairs. All patients with LVT underwent intraoperative thrombectomy. Postoperative outcomes included ischemic and hemorrhagic stroke, pump thrombosis, infectious complications, ventricular arrhythmias, duration of device support, and postoperative echocardiographic parameters. Results: After matching, baseline characteristics were generally comparable. Ischemic stroke incidence was identical (4.8% vs. 4.8%). Hemorrhagic stroke occurred in one LVT patient (4.8%) and in none of the controls. Pump thrombosis was numerically higher in LVT patients (9.5% vs. 4.8%) but not statistically significant. Rates of driveline infection (33.3% vs. 57.1%), bloodstream infection (19.0% vs. 28.6%), and ventricular arrhythmias (19.0% vs. 23.8%) were similar. Postoperative echocardiographic parameters and aortic valve opening patterns were comparable. The median LVAD support duration did not differ significantly (1003 vs. 821 days). Conclusions: Preoperative LVT was not associated with statistically significant differences in adverse outcomes following LVAD implantation when managed with surgical thrombectomy and standardized anticoagulation. However, given the small matched cohort and wide confidence intervals, clinically meaningful differences cannot be excluded. These findings require confirmation in larger prospective studies.

Journal of Clinical MedicineVol. 15(9)
Ege University (TR), Şanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi (TR)
Openalex Percentile: Top 8%
Mechanical Circulatory Support Devices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.